Eversept Partners’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.1M | Buy |
2,383,055
+484,251
| +26% | +$11.4M | 5.16% | 3 |
|
2025
Q1 | $45.6M | Buy |
1,898,804
+298,789
| +19% | +$7.18M | 4.63% | 5 |
|
2024
Q4 | $67.7M | Sell |
1,600,015
-450,142
| -22% | -$19M | 6.01% | 3 |
|
2024
Q3 | $90.6M | Buy |
2,050,157
+6,943
| +0.3% | +$307K | 6.21% | 3 |
|
2024
Q2 | $73.9M | Buy |
2,043,214
+219,433
| +12% | +$7.94M | 5.06% | 7 |
|
2024
Q1 | $78.6M | Sell |
1,823,781
-91,049
| -5% | -$3.93M | 5.25% | 5 |
|
2023
Q4 | $29.5M | Buy |
1,914,830
+436,341
| +30% | +$6.71M | 2.59% | 12 |
|
2023
Q3 | $20.3M | Sell |
1,478,489
-262,462
| -15% | -$3.6M | 1.72% | 14 |
|
2023
Q2 | $27.9M | Sell |
1,740,951
-47,578
| -3% | -$764K | 2.34% | 9 |
|
2023
Q1 | $13.9M | Buy |
1,788,529
+1,377,221
| +335% | +$10.7M | 0.97% | 21 |
|
2022
Q4 | $7.96M | Buy |
411,308
+255,179
| +163% | +$4.94M | 0.7% | 32 |
|
2022
Q3 | $3.33M | Buy |
+156,129
| New | +$3.33M | 0.29% | 37 |
|